Public Variant Databases: Important Considerations
| dc.contributor.author | Bowles, Karla | |
| dc.date.accessioned | 2014-12-22T17:16:55Z | |
| dc.date.available | 2014-12-22T17:16:55Z | |
| dc.date.issued | 2014-12-03 | |
| dc.description | This is an archival copy of an email sent by Myriad Genetics on 12 June 2014 to subscribers of Marketing Information. The video link on the email is no longer accessible, so the video content has been uploaded here in mp4 format. (If the file does not play on your computer, we recommend trying a different video player -- RealPlayer and Windows Media Player have both worked, but there are sometimes issues playing the file with QuickTime. Alternatively, you can convert the file to a format compatible with the video player you wish to use.) These materials are being provided as part of the research files for the following publications: Cheon JY, Mozersky J, Cook-Deegan R. Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Medicine 2014, 6: 121 (19 Dec). AND Angrist M, Cook-Deegan R. Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them. Applied & Translational Genomics 2014 3(4): 124-127. | |
| dc.identifier.uri | ||
| dc.language.iso | en_US | |
| dc.publisher | Myriad Genetics | |
| dc.title | Public Variant Databases: Important Considerations | |
| dc.type | Video |